Analystreport

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its price target lowered by analysts at Guggenheim from $30.00 to $22.00.

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report